A detailed history of Profund Advisors LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 39,971 shares of RNA stock, worth $1.26 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
39,971
Previous 21,426 86.55%
Holding current value
$1.26 Million
Previous $875,000 109.71%
% of portfolio
0.07%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$37.21 - $48.14 $690,059 - $892,756
18,545 Added 86.55%
39,971 $1.84 Million
Q2 2024

Aug 13, 2024

SELL
$22.73 - $40.85 $241,551 - $434,112
-10,627 Reduced 33.15%
21,426 $875,000
Q1 2024

May 08, 2024

SELL
$9.16 - $25.52 $6,476 - $18,042
-707 Reduced 2.16%
32,053 $817,000
Q4 2023

Feb 14, 2024

SELL
$4.87 - $9.37 $111,820 - $215,144
-22,961 Reduced 41.21%
32,760 $296,000
Q3 2023

Nov 13, 2023

SELL
$6.3 - $11.35 $270,799 - $487,868
-42,984 Reduced 43.55%
55,721 $355,000
Q2 2023

Aug 10, 2023

BUY
$10.62 - $17.34 $439,030 - $716,835
41,340 Added 72.06%
98,705 $1.09 Million
Q1 2023

May 11, 2023

BUY
$15.35 - $25.65 $880,552 - $1.47 Million
57,365 New
57,365 $880,000

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.65B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.